Erlotinib Completed Phase 2 Trials for Recurrent Colon Cancer / Recurrent Rectal Cancer / Adenocarcinoma of the Colon / Metastatic Colon Cancer / Adenocarcinoma of the Rectum / Stage IV Rectal Cancer Treatment